Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Perlara and Rambam Medical Center enter APOL1 kidney disease partnership

Dec. 28, 2018

First patient dosed in pivotal phase III PROTECT study of sparsentan

Dec. 28, 2018

Antiviral response damages kidney in bacterial sepsis

Dec. 14, 2018

New phase IIb trial investigates efficacy of male contraceptive gel

Nov. 29, 2018

Dimerix begins dosing in phase II trials of DMX-200 for kidney disease

Nov. 23, 2018

Nash Pharmaceuticals reports data on NP-135 in mouse model of kidney fibrosis

Nov. 20, 2018

Calliditas begins phase III study of Nefecon in IgA nephropathy

Nov. 14, 2018

Swedish Medical Products Agency allows initiation of phase I trial of ROSgard

Nov. 13, 2018

Mutations in DKGE cause C3 glomerulopathy

Nov. 12, 2018

Purinergic receptor mutations cause congenital neurogenic bladder

Nov. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...